Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

about

Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins.Probiotics: A Promising Role in Dental Health.

P2860

Q50310476-6C1C4ECC-8C33-48CF-96DA-82A48A2EAFC1 Q52643961-D80E8152-17A8-43F8-A537-4385A4CB7950

P2860

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

Item

http://www.wikidata.org/entity/Q54232753

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@en

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@nl

type

Item

label

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@en

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@nl

prefLabel

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@en

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@nl

P1476

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

@en

P2860

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.

In situ delivery of cytokines by genetically engineered Lactococcus lactis.

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.

Designer probiotics for prevention of enteric infections.

EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells.

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis.

Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

P2888

nm0117-5

P304

5-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM0117-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amy Maxmen

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28060795

http://www.w3.org/2001/XMLSchema#string

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

about

P2860

P2860

Living therapeutics: Scientists genetically modify bacteria to deliver drugs.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698